clofazimine has been researched along with rifapentine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Cynamon, MH; Klemens, SP; Swenson, CE | 1 |
Casal Román, M; González Requero, AI; Rodríguez López, F; Villalba Montoro, R | 1 |
Cole, ST; Dhar, N; Hartkoorn, RC; Mendoza-Losana, A; Sala, C; Zhang, M | 1 |
Ammerman, NC; Chaisson, RE; Chang, YS; Grosset, JH; Jain, S; Nuermberger, E; Saini, V; Tasneen, R | 1 |
Almeida, DV; Converse, PJ; Nuermberger, EL; Tyagi, S; Xu, J | 1 |
6 other study(ies) available for clofazimine and rifapentine
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
TLC G-65 in combination with other agents in the therapy of Mycobacterium avium infection in beige mice.
Topics: Amikacin; Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Culture Media; Drug Therapy, Combination; Erythromycin; Ethambutol; Gentamicins; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifampin; Tuberculosis | 1992 |
[In vitro activity of clofazimine alone and in combination with amikacin, roxithromycin, rifampicin and rifapentine against Mycobacterium avium-intracellulare].
Topics: Amikacin; Clofazimine; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Mycobacterium avium Complex; Rifampin; Roxithromycin | 1989 |
Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis.
Topics: Acetamides; Amino Acid Sequence; Animals; Antitubercular Agents; Clofazimine; Diarylquinolines; Disease Models, Animal; Drug Discovery; Drugs, Investigational; Female; Genetic Engineering; Latent Tuberculosis; Linezolid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Sequence Data; Mycobacterium tuberculosis; Oxazines; Oxazolidinones; Quinolines; Rifampin; Streptomycin; Structure-Activity Relationship; Xanthenes | 2012 |
Treatment-Shortening Effect of a Novel Regimen Combining Clofazimine and High-Dose Rifapentine in Pathologically Distinct Mouse Models of Tuberculosis.
Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Clofazimine; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Rifampin; Tuberculosis | 2019 |
Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Buruli Ulcer; Clarithromycin; Clofazimine; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Electron Transport; Humans; Imidazoles; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium ulcerans; Piperidines; Pyridines; Rifampin; Streptomycin | 2019 |